Amen... and if there is value with the IP (which I believe there is some) Ronin will get it on a "risk adjusted basis" ie... BP pays for the cost to develop it. If the MSK excitement is real (and I verified that the excitement is real from someone in the trenches) there will be interest from BP cause last time I checked, BP as a group are still greedy snakes.
And I don't see BP coming to rescue the current BOD. Why not wait for Ronin to take the helm?
And why would Ronin "push" the IP value right now? Put his guys in place and put the incentives in place and then we take off.
Peregrine must immediately cease all clinical development activities
Here's the rub...
WHAT "CLINICAL ACTIVITIES"?!?!?!
The ONLY potential "CLINICAL ACTIVITIES" are at NCCN and have already been paid for as far as PPHM is concerned.
Will Avid provide the APP to NCCN for FREE? Is that the Ronin concern?
Maybe the letter should have stated to cease all pre clinical activity and place all future clinical activity on hold until the company is on firm financial footing.
Again, Peregrine has ZERO "clinical activity" at this time.